Proteus mirabilis in Urinary Tract Infections: Pathogenesis, Epidemiology and Antimicrobial Resistance

Zuzanna Trześniewska-Ofiara; Mariola Mendrycka

doi:10.2478/bgbl-2026-0008

.blurhash-client-img { display: none !important; }

Proteus mirabilis in Urinary Tract Infections: Pathogenesis, Epidemiology and Antimicrobial Resistance

Biuletyn Głównej Biblioteki Lekarskiej

Volume 59 (2026): Issue 386 (June 2026)

By: Zuzanna Trześniewska-Ofiara and Mariola Mendrycka

Open Access

|Jun 2026

Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Philadelphia: Elsevier; 2020.
Search in Google Scholar Back to article
Kranz J, Bartoletti R, Bruyère F, Cai T, Geerlings S, Köves B, et al. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. Eur Urol. 2024 Jul;86(1):27–41. doi: 10.1016/j.eururo.2024.03.035.
Open DOI Search in Google Scholar Back to article
McGloin JM, Gordon P, Feeser B, Anderson J, Joyner S, Bentick J, et al. Catheter-associated urinary tract infection (CAUTI) reduction in a neuroscience intensive care unit: a multidisciplinary approach. Am J Infect Control. 2024;52(3):368–370. doi:10.1016/j.ajic.2023.11.016.
Open DOI Search in Google Scholar Back to article
Chakkour M, Hammoud Z, Farhat S, El Roz A, Ezzeddine Z, Ghssein G. Overview of Proteus mirabilis pathogenicity and virulence: insights into the role of metals. Front Microbiol. 2024;15:1383618. doi:10.3389/fmicb.2024.1383618.
Open DOI Search in Google Scholar Back to article
Yang A, Tian Y, Li X. Unveiling the hidden arsenal: New insights into Proteus mirabilis virulence in UTIs. Front Cell Infect Microbiol. 2024;14:1465460. doi:10.3389/fcimb.2024.1465460.
Open DOI Search in Google Scholar Back to article
Kynshi MAL, Kharkamni E, Borah VV. Proteus mirabilis: insights into biofilm formation, virulence mechanisms, and novel therapeutic strategies. Microbe. 2025;7:100450. doi:10.1016/j.microb.2025.100450.
Open DOI Search in Google Scholar Back to article
Hafiz TA, Alghamdi GS, Alkudmani ZS, Alyami AS, AlMazyed A, Alhumaidan OS, et al. Multidrug-resistant Proteus mirabilis infections and clinical outcome at tertiary hospital in Riyadh, Saudi Arabia. Infect Drug Resist. 2024;17:571–581. doi:10.2147/IDR.S448335.
Open DOI Search in Google Scholar Back to article
Zhang P, Cheng Z, Cao Y, Liu S, Zhao M. Genomic epidemiology of antimicrobial resistance in Proteus mirabilis: core genome and plasmid-mediated drivers. BMC Microbiol. 2026;26:89. doi:10.1186/s12866-025-04651-8.
Open DOI Search in Google Scholar Back to article
Yuan F, Huang Z, Yang T, Wang G, Li P, Yang B, et al. Pathogenesis of Proteus mirabilis in catheter-associated urinary tract infections. Urol Int. 2021;105(5-6):354–361. doi: 10.1159/000514097.
Open DOI Search in Google Scholar Back to article
Tegegne DT, Abbott IJ, Poźniak B. Catheter-associated urinary tract infections: understanding the interplay between bacterial biofilm and antimicrobial resistance. Int J Mol Sci. 2025;26(18):9193. doi:10.3390/ijms26189193.
Open DOI Search in Google Scholar Back to article
Wasfi R, Hamed SM, Amer MA, Fahmy LI. Proteus mirabilis biofilm: development and therapeutic strategies. Front Cell Infect Microbiol. 2020;10:414. doi:10.3389/fcimb.2020.00414.
Open DOI Search in Google Scholar Back to article
Armbruster CE, Mobley HLT, Pearson MM. Pathogenesis of Proteus mirabilis infection. EcoSal Plus. 2018;8(1):ESP-0009-2017. doi:10.1128/ecosalplus.ESP-0009-2017.
Open DOI Search in Google Scholar Back to article
Schaffer JN, Pearson MM. Proteus mirabilis and urinary tract infections. Microbiol Spectr. 2015;3(5):UTI-0017-2013. doi:10.1128/microbiolspec.UTI-0017-2013.
Open DOI Search in Google Scholar Back to article
Yang A, Cai Y, Zhang Z, Xu Y, Shen C, Wang W, et al. Decoding the regulatory networks of Proteus mirabilis under succinic acid stress: a multi-omics approach. Front Cell Infect Microbiol. 2025 Oct 3;15:1650340. doi: 10.3389/fcimb.2025.1650340.
Open DOI Search in Google Scholar Back to article
Stickler DJ. Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol. 2008;5(11):598–608. doi:10.1038/ncpuro1231.
Open DOI Search in Google Scholar Back to article
Trześniewska-Ofiara Z, Mendrycka M, Woźniak-Kosek A. Bacterial biofilm as a contributor to urinary tract infection. Biul Gł Bibl Lek. 2025;384:83–102. doi:10.2478/bgbl-2025-0008.
Open DOI Search in Google Scholar Back to article
Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322–332. doi:10.1016/j.ijantimicag.2009.12.011.
Open DOI Search in Google Scholar Back to article
Tseng BS, Zhang W, Harrison JJ, Quach TP, Song JL, Penterman J, et al. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ Microbiol. 2013;15(10):2865–2878. doi:10.1111/1462-2920.12155.
Open DOI Search in Google Scholar Back to article
Filipiak A, Chrapek M, Literacka E, Wawszczak M, Głuszek S, Majchrzak M, et al. Pathogenic factors correlate with antimicrobial resistance among clinical Proteus mirabilis strains. Front Microbiol. 2020;11:579389. doi:10.3389/fmicb.2020.579389.
Open DOI Search in Google Scholar Back to article
Fahem WD, Abdullah SN, Abbood HAR. A study on quorum sensing gene gen luxS and mixed biofilm dynamics of Proteus mirabilis and Candida albicans in urinary tract infections. Basrah J Sci. 2026;44(1). doi:10.29072/4369s803.
Open DOI Search in Google Scholar Back to article
Hetta HF, Ramadan YN, Rashed ZI, Alharbi AA, Alsharef S, Alkindy TT, et al. Quorum sensing inhibitors: an alternative strategy to win the battle against multidrug-resistant (MDR) bacteria. Molecules. 2024;29(15):3466. doi:10.3390/molecules29153466.
Open DOI Search in Google Scholar Back to article
Hu Y, Ma W, Tang K, Qi Q, Xu W, Hu R, et al. Global burden of urinary tract infections in older women from 1990 to 2021 with projections to 2040: a trend analysis of the Global Burden of Disease Study 2021. Front Cell Infect Microbiol. 2025;15:1577777. doi:10.3389/fcimb.2025.1577777.
Open DOI Search in Google Scholar Back to article
Guterman LB, Motsay M, Hunt BC, Brauer AL, Learman BS, Wijayahena MK, et al. Harnessing microbial-derived metabolites in the urinary tract to prevent infection induced catheter encrustation. Nat Commun. 2025;16:9678. doi:10.1038/s41467-025-64661-y.
Open DOI Search in Google Scholar Back to article
Veisi M, Hosseini-Nave H, Tadjrobehkar O. Biofilm formation ability and swarming motility are associated with some virulence genes in Proteus mirabilis. BMC Microbiol. 2025;25:90. doi:10.1186/s12866-025-04090-5.
Open DOI Search in Google Scholar Back to article
Al-Qurashi E, Elbnna K, Ahmad I, Abulreesh HH. Antibiotic resistance in Proteus mirabilis: mechanism, status, and public health significance. J Pure Appl Microbiol. 2022;16(3):1550–1561. doi:10.22207/JPAM.16.3.59.
Open DOI Search in Google Scholar Back to article
Trautner BW, Cortés-Penfield NW, Gupta K, Hirsch EB, Horstman M, Moran GJ, et al. Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Duration of Antibiotics for Complicated UTI. Clin Infect Dis. 2025. doi:10.1093/cid/ciaf462.
Open DOI Search in Google Scholar Back to article
Mo L, Wang J, Qian J, Peng M. Antibiotic sensitivity of Proteus mirabilis urinary tract infection in patients with urinary calculi. Int J Clin Pract. 2022;2022:7273627. doi:10.1155/2022/7273627.
Open DOI Search in Google Scholar Back to article
de Oliveira WD, Barboza MGL, Faustino G, Inagaki WTY, Sanches MS, Kobayashi RKT, et al. Virulence, resistance and clonality of Proteus mirabilis isolated from patients with community-acquired urinary tract infection (CA-UTI) in Brazil. Microb Pathog. 2021;152:104642. doi:10.1016/j.micpath.2020.104642.
Open DOI Search in Google Scholar Back to article
World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2024. Geneva: World Health Organization; 2024. Available from: https://www.who.int/initiatives/glass.
Search in Google Scholar Back to article
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990– 2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199–1226. doi:10.1016/S0140-6736(24)01867-1.
Open DOI Search in Google Scholar Back to article
Literacka E, Izdebski R, Baraniak A, Żabicka D, Schneider A, Urbanowicz P, et al. Proteus mirabilis producing the OXA-58 carbapenemase in Poland. Antimicrob Agents Chemother. 2019;63(5):e00106-19. doi:10.1128/AAC.00106-19.
Open DOI Search in Google Scholar Back to article
Trześniewska-Ofiara Z, Mendrycka M, Woźniak-Kosek A. Drug susceptibility of uropathogens isolated from patients treated at the Mazovian Specialized Hospital in Radom. Acta Biochim Pol. 2025;72:14082. doi:10.3389/abp.2025.14082.
Open DOI Search in Google Scholar Back to article
Baraniak A, Izdebski R, Fiett J, Gawryszewska I, Bojarska K, Herda M, et al. NDM-producing Enterobacteriaceae in Poland, 2012–14: inter-regional outbreak of Klebsiella pneumoniae ST11 and sporadic cases. J Antimicrob Chemother. 2016;71(1):85–91. doi:10.1093/jac/dkv282.
Open DOI Search in Google Scholar Back to article
Ochmerak J, Potocki L, Kusliśkiewicz M. Antidotum na bakterie chorobotwórcze – nowe spojrzenie na bakteriofagi. Pol J Sustain Dev. 2024;28(1):157–166. doi:10.15584/pjsd.2024.28.1.16.
Open DOI Search in Google Scholar Back to article
Milcarz A. Bakteriofagi i ich potencjał w leczeniu infekcji oraz zwiększaniu bezpieczeństwa żywności. Nauki Inżynierskie i Technologie. 2024;(40):128–138. doi:10.15611/nit.2024.40.11.
Open DOI Search in Google Scholar Back to article
Kochel-Karakulska J, Czajkowski A, Olszewska P, Miłek D, Spietelun M, Nawrotek P. Bakteriofagi – wczoraj, dziś, jutro. Kosmos. 2024;73(3):459–470. doi:10.36921/kos.2024_3042.
Open DOI Search in Google Scholar Back to article
Marcon J, Schubert S, Stief CG, Magistro G. In vitro efficacy of phytotherapeutics suggested for prevention and therapy of urinary tractin infections. Infection. 2019;47(6):937–944. doi:10.1007/s15010-019-01315-4.
Open DOI Search in Google Scholar Back to article
Sharif S, Yadav AK. Bacterial biofilm and its role in antibiotic resistance. Microbe. 2025;7:100356. doi:10.1016/j.microb.2025.100356.
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/bgbl-2026-0008 | Journal eISSN: 2956-6851 | Journal ISSN: 0373-174X

Journal RSS Feed

Language: English

Page range: 123 - 144

Accepted on: Jun 3, 2026

Published on: Jun 28, 2026

Published by: The Medical Library named after S. Konopka in Warsaw

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Proteus mirabilis,

urinary tract infections,

catheter-associated infections,

crystalline biofilm,

struvite urolithiasis,

virulence factors,

antimicrobial resistance

Related subjects:

Medicine,

Biomedical engineering

© 2026 Zuzanna Trześniewska-Ofiara, Mariola Mendrycka, published by The Medical Library named after S. Konopka in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 59 (2026): Issue 386 (June 2026)